Option chain shows key data for Oxford BioMedica's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Oxford BioMedica.

Oxford BioMedica (OTC:OXBDF) Stock, Option Chain

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types.

Biotech

Large Cap

News

Penny Stocks

Health Care

Financing

Offerings

Small Cap

Management

General

AKBA

AZNCF

ENDP

GILD

GMAB

NKTR

NRXP

OTSKF

OTSKY

OXBDF

PRVB

XFOR

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

$BTC

$ETH

AAPL

AMZN

BNPQY

DINO

FTCV

GOOG

GOOGL

HYMTF

SEAC

SZKMY

TSLA

CNBC

Why Kohl’s Shares Are Plunging Today

Benzinga Before The Bell: Kohl&#39;s Deal Talks Cancellation, Tesla&#39;s Racial Discrimination Lawsuit, Nio&#39;s Strong June Deliveries And Other Top Financial Stories Friday, July 1

Contracts

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca&#39;s COVID-19 Vaccine

OXFORD BIOMEDICA PLC NEW by Oxford Biomedica PLC

Oxford BioMedica PLC

Oxford BioMedica (GB:OXB) has released an update. Oxford BioMedica PLC has reported a significant change in its shareholder structure, with investm...

BlackRock Surpasses 5% Stake in Oxford BioMedica

Oxford BioMedica (GB:OXB) has released an update. Oxford BioMedica PLC has announced a significant change in shareholder voting rights, with invest...

BlackRock Adjusts Stake in Oxford BioMedica

Oxford BioMedica (GB:OXB) has released an update. Oxford Biomedica plc has granted nil-cost share options to its top executives under the 2024 Long...

Oxford Biomedica Executives Granted Share Options

Oxford BioMedica (GB:OXB) has released an update. Oxford Biomedica has applied for a block listing on the London Stock Exchange for 800,000 ordinar...

Oxford Biomedica Seeks Stock Market Expansion

JPMorgan raised the firm's price target on Oxford Biomedica (OXBDF) to 450 GBp from 305 GBp and keeps a Neutral rating on the shares. Published fir...

Oxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorgan

Oxford BioMedica (GB:OXB) has released an update. Oxford BioMedica has reported a change in its voting rights, with Liontrust Investment Partners L...

Oxford BioMedica Sees Shift in Voting Rights

Oxford BioMedica (GB:OXB) has released an update. Oxford Biomedica has announced the granting of nil-cost share options under its 2024 Long Term In...

Oxford Biomedica Grants Share Options to Key Personnel

Oxford BioMedica (GB:OXB) has released an update. Oxford BioMedica is set to showcase its expertise in cell and gene therapy at the upcoming Jeffer...

Oxford BioMedica to Present at Healthcare Conference

Oxford BioMedica (GB:OXB) has released an update. Oxford Biomedica has appointed Colin Bond as a Non-Executive Director, effective January 2025, as...

Oxford Biomedica Strengthens Board with Key Appointment

Oxford BioMedica (GB:OXB) has released an update. Oxford Biomedica has announced a new long-term incentive plan for Mark Caswell, the Site Head of ...

Comments

Oxford BioMedica

Oxford BioMedica (OXBDF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga